http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2008026769-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
filingDate 2007-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-WO2008026769-A1
titleOfInvention Novel aminopyridine derivatives having selective inhibition of Aurora A
abstract The present invention relates to general formula [I]: [Wherein R 1 is a hydrogen atom, F, CN or the like; R 1 ′ is a hydrogen atom or an optionally substituted lower alkyl group; R 2 is O, S, SO, SO 2 or the like. R 3 is an optionally substituted phenyl group; X 1 , X 2 , and X 3 are each independently CH, N, etc. provided that X 1 , X 2 , and X 3 has 0 to 1 N; W is the following group: Here, W 1 , W 2 , and W 3 are each independently CH, N, and the like. Or a pharmaceutically acceptable salt or ester thereof.
priorityDate 2006-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468308159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431745410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431745420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1991452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59152154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431745424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409820478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409750351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24853233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409820481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59152167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433687416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5323974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87251808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59152186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466425073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59682960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433344915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466425192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467858967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59682942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59152213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466425209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59152207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431745429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59152181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466258365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467234760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433344903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433687386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421262801

Total number of triples: 59.